The Nexfin monitors are said to provide provide precise and easy to use continuous non-invasive blood pressure and cardiac output monitoring. Bmeye received CE market approval earlier this year.
Bill Bednarski, CEO of Bmeye, said: “The Nexfin is cost effective and will significantly improve patient care.”